// App-Quantinova.ai

P636 : Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy

Researchers

Presenter

  • Silvia Guglietta

Principal Investigators

  • Lukas M Weber

  • Bruno Fosso

  • Gary Hardiman

  • Monica M Olcina

  • Marinella Marzano

  • Mark D Robinson

  • Carsten Krieg

Medical Centers

  • Medical University of South Carolina,

  • Department of International Health

  • Johns Hopkins Bloomberg Sch. of Public Hlth.

  • Consiglio Nazionale delle Ricerche

  • Queens Univ. Belfast

  • Univ of Oxford

  • Univ. of Zurich

Locations

  • Puerto Rico

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

Disease

  • Colorectal Cancer

  • Chronic obstructive pulmonary disease

Biomarkers

  • Complement Component 3a

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved